C7221ZZ
Tomographic (Tomo) Nuclear Medicine Imaging Spleen to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | 2 Spleen |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
Tomographic nuclear medicine imaging of the lymphatic and hematologic system produces three-dimensional pictures built from radioactive emissions captured as a detector rotates around the patient, offering more spatial detail than a flat, single-plane scan. Common applications include imaging the spleen to evaluate its size, function, or the presence of accessory spleen tissue, and bone marrow scans that assess how well marrow is producing blood cells across the skeleton.
These studies are typically ordered when a flat image would not give enough detail to answer the clinical question, such as when a physician needs to see the exact three-dimensional distribution of functioning marrow, or precisely localize splenic tissue before a planned surgery. The added detail comes from the same rotational data-collection principle used in other tomographic nuclear medicine studies, just applied to lymphatic and blood-forming tissue rather than another organ system.
Anatomy & Axis Detail
Spleen
Tomographic imaging of the spleen, typically performed as SPECT following administration of a technetium-99m sulfur colloid or heat-damaged autologous red blood cells, exploits the organ's dense reticuloendothelial and reticulocyte-clearing activity to generate cross-sectional maps of splenic tissue. This approach is used to confirm splenic size, position, and functional parenchyma when anatomic imaging is equivocal, to detect accessory spleens or splenosis after splenectomy, and to distinguish an upper abdominal mass from splenic tissue. Because the spleen sits adjacent to the left kidney, stomach, and colon, three-dimensional reconstruction is particularly valuable for separating overlapping activity that a single planar view would obscure. Reduced or absent uptake can indicate infarction, atrophy, or functional asplenia, while focal photopenic defects raise concern for cysts, abscess, or infiltrative disease within the splenic parenchyma.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
Documentation needs to establish that the images were reconstructed from a rotational, three-dimensional acquisition rather than a series of flat views, since this is the feature that separates this root operation from planar imaging of the same body system. The specific organ or tissue studied, such as spleen versus bone marrow, should be clearly identified because it drives body part selection. A recurring error is coding a tomographic marrow or spleen study as a general "blood" study without pinning down the actual anatomic target documented in the radiology report.
Commonly Confused With
The closest source of confusion is Planar Nuclear Medicine Imaging of the same body system; both use similar tracers and target the same organs, but the tomographic version is reserved for studies that specifically reconstruct a three-dimensional volume rather than capturing single flat views. It can also be confused with PET imaging of other body systems when FDG is used for lymphoma staging, but lymphoma PET studies are typically coded under a whole-body or different body-system category rather than this lymphatic and hematologic tomographic family, depending on what the report actually documents.